⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12473533 | 0.78 | — | — | |
| SCHEMBL928768 | 0.75 | — | — | |
| SCHEMBL5669318 | 0.75 | HDAC6 (0.42) | — | |
| SCHEMBL67112 | 0.73 | — | — | |
| SCHEMBL7565642 | 0.73 | — | — | |
| SCHEMBL3895083 | 0.71 | — | — | |
| SCHEMBL294551 | 0.71 | — | — | |
| SCHEMBL929676 | 0.71 | — | — | |
| SCHEMBL1040561 | 0.71 | — | — | |
| SCHEMBL18696265 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0300665-B1 | Cephalosporin compounds, process for their preparation and their pharmaceutical compositions | ZENECA PHARMA SA (FR) | 1995-12-20 | — | — | EP | claimed |
| EP-0304155-B1 | Cephalosporin compounds, process for their preparation and their pharmaceutical compositions | ZENECA PHARMA SA (FR) | 1995-11-15 | — | — | EP | claimed |
| EP-0225182-B1 | CEPHALOSPORIN COMPOUNDS | ICI PHARMA (FR) | 1993-02-10 | — | — | EP | claimed |
| US-5013731-A | Bactericides | ICI PHARMA (FR) | 1991-05-07 | — | — | US | claimed |
| US-5008258-A | Antibiotics | I.C.I.-PHARMA (FR) | 1991-04-16 | — | — | US | claimed |
| EP-0164944-B1 | CEPHALOSPORIN DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-07-11 | — | — | EP | claimed |
| US-4868173-A | CONTAIN AMINE SALT GROUP | ICI PHARMA (FR) | 1989-09-19 | — | — | US | claimed |
| EP-0304155-A2 | Cephalosporin compounds, process for their preparation and their pharmaceutical compositions | ZENECA Pharma S.A. (FR) | 1989-02-22 | — | — | EP | claimed |
| EP-0300664-A2 | Cephalosporin compounds | ZENECA Pharma S.A. (FR) | 1989-01-25 | — | — | EP | claimed |
| EP-0300665-A2 | Cephalosporin compounds, process for their preparation and their pharmaceutical compositions | ZENECA Pharma S.A. (FR) | 1989-01-25 | — | — | EP | claimed |
| EP-0225182-A2 | Cephalosporin compounds | ICI PHARMA (FR) | 1987-06-10 | — | — | EP | claimed |
| EP-0182633-A2 | Cephalosporin derivatives | ICI PHARMA (FR) | 1986-05-28 | — | — | EP | claimed |
| EP-0164944-A1 | Cephalosporin derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-12-18 | — | — | EP | claimed |
| US-9446109-B2 | Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2016-09-20 | — | — | US | disclosed |
| US-20140161793-A2 | GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI | INSERM (FR) | 2014-06-12 | — | — | US | disclosed |
| US-20130243751-A1 | GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI | CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE | 2013-09-19 | — | — | US | disclosed |
| EP-0215355-A2 | Erythromycin derivative and process for preparing the same | KITASATO KENKYUSHO (JP) | 1987-03-25 | — | — | EP | disclosed |
| EP-0213617-A2 | Digestive tract contractile motion stimulant | KITASATO KENKYUSHO (JP) | 1987-03-11 | — | — | EP | disclosed |
| EP-0182633-A2 | Cephalosporin derivatives | ICI PHARMA (FR) | 1986-05-28 | — | — | EP | disclosed |
| EP-0164944-A1 | Cephalosporin derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-12-18 | — | — | EP | disclosed |